Alzamend Neuro, Inc. (ALZN) Financials
ALZN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Oct. 31, 2023 | 983597 | 3.7 million |
| July 31, 2023 | 2.6 million | 2.7 million |
| April 30, 2023 | 5.9 million | 2.9 million |
| Jan. 31, 2023 | 8.5 million | 2.6 million |
ALZN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Oct. 31, 2023 | -1.5 million | 318336 |
| July 31, 2023 | -3.4 million | 369380 |
| April 30, 2023 | -2.2 million | 491326 |
| Jan. 31, 2023 | -1.8 million | 1.5 million |
ALZN Net Income
No data available :(
ALZN Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Oct. 31, 2023 | 200079 | - | - |
| July 31, 2023 | 1.7 million | - | - |
| April 30, 2023 | 5.1 million | - | - |
| Jan. 31, 2023 | 7.4 million | - | - |
ALZN Shares Outstanding
ALZN Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Oct. 31, 2023 | - | 2.0 million | 904939 | - |
| July 31, 2023 | 147243 | 2.4 million | 912460 | 247334 |
| April 30, 2023 | 147243 | 1.6 million | 1.4 million | 247334 |
| Jan. 31, 2023 | 147243 | 2.9 million | 2.5 million | 247333 |
ALZN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Oct. 31, 2023 | - | 12685 |
| July 31, 2023 | - | 12685 |
| April 30, 2023 | - | 5323 |
| Jan. 31, 2023 | - | 5323 |
ALZN
Price: $1.22
52 week price:
Earnings Per Share: -2.67 USD
P/E Ratio: -0.74
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 216306
Market Capitalization: 3.6 million